To explore the significance of the CD133–DNMT1 interaction in CD133‐ reduced DNMT1 nuclear translocation, CD133+ glioma cells were expressed CD133 shRNA and either shRNA‐resistant wild‐type CD133 or shRNA‐resistant CD133(1–862) mutant. This evidence concerns the gene PROM1 and central nervous system cancer.